Literature DB >> 6250497

Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons.

D Rosner, R N Bedwani, J Vana, H W Baker, G P Murphy.   

Abstract

This study evaluates the data of noninvasive (in situ) lobular (ISLC) and ductal (ISDC) carcinoma, collected from 498 hospitals in a National Breast Cancer Survey, carried out by the American College of Surgeons in 1978. ISLC and ISDC were identified in 323 (3.2%) of 10,054 female patients with lobular and ductal carcinoma, of the total of 23,972 patients with histologically proven breast cancer surveyed (1.4%). The frequency of ISLC was significantly higher (18.5%) than ISDC (2.1%) suggesting a less agressive nature of ISLC, with a slower progression to invasion than ISDC. There was a different age distribution of ISLC and ISDC: about 80% of ISLC and 50% of ISDC were diagnosed in patients who were less than 54 years old, and the incidence showed a marked decrease in the older age groups in ISLC, whereas the incidence remained high in the following decade in ISDC. In this series there was a distinctly better five-year cure rate in the patients with ISLC (83.5%) than in the patients with ISDC (68.8%), in spite of the fact that radical surgery was performed more frequently in ISDC (67.8%) than ISLC (36.3%). The recurrence rate was five times higher (10.5%) in ISDC than in ISLC (2.5%). In black patients the recurrence rate (21.3%) was significantly higher in ISDC than in white patients (9.3%). In the present study there were no statistically significant differences in the five-year cure and recurrence rate in patients with noninvasive carcinoma, treated by more conservative procedures (72.9% and 8.5%) and those treated by more extensive surgeries (76.2% and 7.7%). The results of this study suggests that the biologic behavior of ISLC and ISDC may be different with regard to their propensity to invade and their overall prognosis. In contrast, the infiltrative form of lobular and ductal carcinoma, were found to have the same prognosis, regardless of the type of operative procedure performed.

Entities:  

Mesh:

Year:  1980        PMID: 6250497      PMCID: PMC1344842          DOI: 10.1097/00000658-198008000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  27 in total

1.  Lobular carcinoma in situ: A rare form of mammary cancer.

Authors:  F W Foote; F W Stewart
Journal:  Am J Pathol       Date:  1941-07       Impact factor: 4.307

2.  Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment.

Authors:  P P Rosen; R Senie; D Schottenfeld; R Ashikari
Journal:  Ann Surg       Date:  1979-03       Impact factor: 12.969

3.  Histologic changes in incipient carcinoma of the breast.

Authors:  S C Sommers
Journal:  Cancer       Date:  1969-04       Impact factor: 6.860

4.  Neoplastic proliferation of the epithelium of the mammary lobules: adenosis, lobular neoplasia, and small cell carcinoma.

Authors:  C D Haagensen; N Lane; R Lattes
Journal:  Surg Clin North Am       Date:  1972-04       Impact factor: 2.741

5.  Lobular carcinoma in situ. Long term follow-up.

Authors:  R V Hutter; F W Foote
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

6.  Lobular carcinoma of the breast.

Authors:  N E Warner
Journal:  Cancer       Date:  1969-04       Impact factor: 6.860

7.  Implications from SEER data on breast cancer management.

Authors:  C R Smart; M H Myers; L A Gloeckler
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

8.  Lobular carcinoma of the female breast. Report of 73 cases.

Authors:  W Newman
Journal:  Ann Surg       Date:  1966-08       Impact factor: 12.969

Review 9.  Lobular carcinoma of the breast: an overview.

Authors:  E R Fisher; B Fisher
Journal:  Ann Surg       Date:  1977-04       Impact factor: 12.969

10.  Experience with lobular carcinoma of the breast. Emphasis on recent aspects of management.

Authors:  R P Davis; P F Nora; R G Kooy; J R Hines
Journal:  Arch Surg       Date:  1979-04
View more
  35 in total

1.  Ductal Carcinoma In Situ of the Breast: Is Breast Conserving Treatment Feasible?

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

Review 2.  Imaging for the diagnosis and management of ductal carcinoma in situ.

Authors:  Carl J D'Orsi
Journal:  J Natl Cancer Inst Monogr       Date:  2010

3.  The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ.

Authors:  Kaoru Itakura; Juan Lessing; Theadora Sakata; Amy Heinzerling; Eline Vriens; Dorota Wisner; Michael Alvarado; Laura Esserman; Cheryl Ewing; Nola Hylton; E Shelley Hwang
Journal:  Clin Breast Cancer       Date:  2011-03       Impact factor: 3.225

4.  Ductal carcinoma in situ: correlations between high-resolution magnetic resonance imaging and histopathology.

Authors:  Yoshihide Kanemaki; Yasuyuki Kurihara; Kyoko Okamoto; Yasuo Nakajima; Mamoru Fukuda; Ichiro Maeda; Futoshi Akiyama
Journal:  Radiat Med       Date:  2007-01-25

5.  Ductal Carcinoma in Situ: Clinical Perspective.

Authors:  Thorsten Kühn
Journal:  Breast Care (Basel)       Date:  2010-08-02       Impact factor: 2.860

6.  Radiotherapy for ductal carcinoma in situ detected by screening.

Authors:  C R Hamilton; R B Buchanan
Journal:  BMJ       Date:  1990-07-28

7.  Natural history of in situ breast cancer in a defined population.

Authors:  W J Temple; M Jenkins; F Alexander; W S Hwang; L H Marx; A W Lees; H T Williams; M G Pambrun
Journal:  Ann Surg       Date:  1989-11       Impact factor: 12.969

8.  Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?

Authors:  Lucía Graña-López; Michel Herranz; Inés Domínguez-Prado; Sonia Argibay; Ángeles Villares; Manuel Vázquez-Caruncho
Journal:  Eur Radiol       Date:  2019-08-02       Impact factor: 5.315

Review 9.  Management of in situ and minimally invasive breast carcinoma.

Authors:  E R Frykberg; K I Bland
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

10.  Treatment of primary breast cancer without mastectomy. The Los Angeles community experience and review of the literature.

Authors: 
Journal:  Ann Surg       Date:  1986-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.